DFFVX
Price
$33.47
Change
+$0.53 (+1.61%)
Updated
Jun 26 closing price
Net Assets
12.72B
HSMFX
Price
$11.75
Change
+$0.22 (+1.91%)
Updated
Jun 26 closing price
Net Assets
171.82M
Interact to see
Advertisement

DFFVX vs HSMFX

Header iconDFFVX vs HSMFX Comparison
Open Charts DFFVX vs HSMFXBanner chart's image
DFA US Targeted Value I
Price$33.47
Change+$0.53 (+1.61%)
VolumeN/A
Net Assets12.72B
Hartford Small Cap Value F
Price$11.75
Change+$0.22 (+1.91%)
VolumeN/A
Net Assets171.82M
DFFVX vs HSMFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DFFVX vs. HSMFX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and HSMFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 12.7B vs. HSMFX (172M). HSMFX pays higher dividends than DFFVX: HSMFX (2.01) vs DFFVX (1.62). DFFVX was incepted earlier than HSMFX: DFFVX (25 years) vs HSMFX (8 years). HSMFX (0.89) is less costly to investors than DFFVX (0.30). HSMFX is a more actively managed with annual turnover of: 46.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than HSMFX: DFFVX (0) vs HSMFX (1000000). DFFVX annual gain was more profitable for investors over the last year : 6.07 vs. HSMFX (0.82). DFFVX return over 5 years is better than : 110.28 vs. HSMFX (68.78).
DFFVXHSMFXDFFVX / HSMFX
Total Expense Ratio0.290.8136%
Annual Report Gross Expense Ratio0.300.8934%
Fund Existence25 years8 years-
Gain YTD-3.741-8.99842%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.7B172M7,384%
Annual Yield % from dividends1.622.0180%
Returns for 1 year6.070.82744%
Returns for 3 years26.0510.76242%
Returns for 5 years110.2868.78160%
Returns for 10 years52.44N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARM0.41N/A
-0.15%
Carisma Therapeutics
NTAP104.75-0.43
-0.41%
NetApp
TIGO36.02-0.46
-1.26%
Millicom International Cellular SA
ZYME12.37-0.34
-2.68%
Zymeworks
LRMR3.08-0.17
-5.23%
Larimar Therapeutics